2011 Case CFAR Annual Conference
2011 Case CFAR Annual Conference
批准号:
8141013
负责人:
JONATHAN KARN
金额:
$2.0万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2011-12-31
关键词:
Acquired Immunodeficiency SyndromeAreaCharacteristicsClinicalClinical TrialsCommunitiesDevelopmentEnsureEpidemicFacultyFemaleFundingGoalsHIVHIV InfectionsImmunologyInstitutionInternationalMalignant NeoplasmsMinorityPathogenesisPublicationsRequest for ApplicationsResearchResearch PersonnelResourcesScientistStructureStudentsTimeTrainingTuberculosisUniversitiesUniversity Hospitalsbasecombatcostexpectationmeetingsmembermicrobicideprogramssymposiumtheoriesvirology
中文摘要
描述(由申请人提供):凯斯西部储备大学/克利夫兰大学医院艾滋病研究中心(凯斯西储大学/克利夫兰大学医院)将于2011年春季主办其年度会议--2011年凯斯西储大学/克利夫兰大学艾滋病研究中心年会。这项申请请求提供支持,以支付与参加Case CFAR会议的女性和少数族裔科学家和学生相关的费用。Case CFAR成立于1994年,旨在促进艾滋病毒感染和艾滋病的研究。CFAR提供核心资源、研讨会、讲座、出版物和发展资金,以促进和加强该大学及其附属机构的艾滋病研究计划。CFAR为我们的174名教职员工提供了重要的国际研究支持(特别是在结核病和艾滋病毒恶性疾病方面的研究)、杀菌剂、发病机制、病毒学、临床试验和培训。1.为与会者,包括我们自己的教职员工和学生,提供国家领先的艾滋病相关研究人员的演讲。2.留出大量时间对最新的与艾滋病有关的研究进行正式和非正式讨论。3.为青年研究人员和学生提供机会,在正式和非正式场合与领先的艾滋病相关研究人员互动。会议形式的结构将最大限度地交流思想,促进科学辩论,鼓励合作项目。鼓励取得这些成果的形式的特点是,出席人数预计不超过125人;事先计划好的集体聚餐旨在提供机会非正式讨论科学理论和合作机会,以及不发表会议报告,从而使尖端意见、想法和理论得以更自由地交流。根据他们在会议主题领域的前沿研究,挑选研究人员在会议上发言,并确保在艾滋病研究的当前问题和方向上纳入不同的观点和理论。Case CFAR积极努力确保将少数群体和女性研究人员纳入会议规划和出席的所有方面。
与公共卫生相关:凯斯西储大学/克利夫兰大学医院艾滋病研究中心(CASE CFAR)将于2011年春季主办其年度会议--2011年CASE CFAR年会。这次会议将有助于推动免疫学和病毒学领域与艾滋病相关的研究。尽管科学研究在了解和治疗艾滋病方面取得了显著进展,但迫切需要进一步了解和取得进展,以抗击这一持续的全球流行病。
英文摘要
DESCRIPTION (provided by applicant): The Case Western Reserve University/University Hospitals of Cleveland Center for AIDS Research (Case CFAR) is hosting its annual conference, the 2011 Case CFAR Annual Conference during the spring of 2011. This application requests support to cover costs associated with participation of female and minority scientists and students in the Case CFAR conference. The Case CFAR, founded in 1994, promotes research in HIV infection and AIDS. The CFAR provides core resources, seminars, lectureships, publication and developmental funding to promote and strengthen the AIDS research programs at the University and its affiliated institutions. The CFAR has provided our 174 faculty members with significant support for international research (especially with respect to research in tuberculosis and HIV malignancy), microbicides, pathogenesis, virology, clinical trials, and training. 1. Providing conference attendees, including our own faculty and students, with presentations from leading national AIDS-related researchers. 2. Allowing extensive time for formal and informal discussion of the most current AIDS-related research. 3. Provide young investigators and students with an opportunity to interact with leading AIDS- related researchers in both formal and informal venues. The conference format will be structured to maximize the interchange of ideas, to promote scientific debate and to encourage collaborative ventures. Characteristics of the format which encourage these results are attendance size, with an expectation of no more than 125 attendees; pre- planned communal meals structured to provide opportunities to informally discuss scientific theory and collaborative opportunities and not-publication of conference presentation, thereby allowing for a freer exchange of cutting-edge opinions, ideas and theories. Researchers are selected to present at the conference based on their cutting-edge research in the session topic area, and to ensure inclusion of differing views and theories on current questions and directions in AIDS research. The Case CFAR is proactive in its effort to ensure inclusion of minority and female researchers in all aspects of conference planning and attendance.
PUBLIC HEALTH RELEVANCE: The Case Western Reserve University/University Hospitals of Cleveland Center for AIDS Research (Case CFAR) is hosting its annual conference, the 2011 Case CFAR Annual Conference during the spring of 2011. The conference will help to advance AIDS-related research in the fields of immunology and virology. Although scientific research has made remarkable progress in understanding and treating AIDS, additional understanding and advances are urgently needed to combat the continued global epidemic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of RNA m6A modification in the regulation of HIV latency and reactivation
-
批准号:10600078
-
项目类别:
-
资助金额:$71.55万
-
财政年份:2022
-
负责人:JONATHAN KARN
-
依托单位:
The role of RNA m6A modification in the regulation of HIV latency and reactivation
-
批准号:10461499
-
项目类别:
-
资助金额:$71.55万
-
财政年份:2022
-
负责人:JONATHAN KARN
-
依托单位:
Research Support Core B: Primary Cell, Biomimetic, and iPSC-derived Cell Models
-
批准号:10304584
-
项目类别:
-
资助金额:$73.12万
-
财政年份:2021
-
负责人:JONATHAN KARN
-
依托单位:
Research Support Core B: Primary Cell, Biomimetic, and iPSC-derived Cell Models
-
批准号:10632094
-
项目类别:
-
资助金额:$73.12万
-
财政年份:2021
-
负责人:JONATHAN KARN
-
依托单位:
New Inhibitors of HIV latency reactivation
-
批准号:10010720
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2020
-
负责人:JONATHAN KARN
-
依托单位:
New Inhibitors of HIV latency reactivation
-
批准号:10208701
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2020
-
负责人:JONATHAN KARN
-
依托单位:
Control of P-TEFb biogenesis and HIV transcription in primary T-cells
-
批准号:10158438
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2019
-
负责人:JONATHAN KARN
-
依托单位:
Regulation of HIV latency by microglial-neuronal interactions
-
批准号:10220927
-
项目类别:
-
资助金额:$79.05万
-
财政年份:2019
-
负责人:JONATHAN KARN
-
依托单位:
Regulation of HIV latency by microglial-neuronal interactions
-
批准号:10674037
-
项目类别:
-
资助金额:$78.49万
-
财政年份:2019
-
负责人:JONATHAN KARN
-
依托单位:
Control of P-TEFb biogenesis and HIV transcription in primary T-cells
-
批准号:10403547
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2019
-
负责人:JONATHAN KARN
-
依托单位:
Regulation of HIV latency by microglial-neuronal interactions
-
批准号:10450662
-
项目类别:
-
资助金额:$78.81万
-
财政年份:2019
-
负责人:JONATHAN KARN
-
依托单位:
Control of P-TEFb biogenesis and HIV transcription in primary T-cells
-
批准号:10629307
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2019
-
负责人:JONATHAN KARN
-
依托单位:
Gene editing strategies to target HIV for elimination in periphery and brain
-
批准号:9140616
-
项目类别:
-
资助金额:$80.4万
-
财政年份:2016
-
负责人:JONATHAN KARN
-
依托单位:
HIV eradication by ADCC-activated NK cell killing
-
批准号:9197413
-
项目类别:
-
资助金额:$47.55万
-
财政年份:2016
-
负责人:JONATHAN KARN
-
依托单位:
Administrative Core A
-
批准号:9241510
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2016
-
负责人:JONATHAN KARN
-
依托单位:
Reversal of HIV latency by METH and Inflammation
-
批准号:9331606
-
项目类别:
-
资助金额:$73.25万
-
财政年份:2016
-
负责人:JONATHAN KARN
-
依托单位:
HIV eradication by ADCC-activated NK cell killing
-
批准号:9243206
-
项目类别:
-
资助金额:$46.94万
-
财政年份:2016
-
负责人:JONATHAN KARN
-
依托单位:
Reversal of HIV latency by METH and Inflammation
-
批准号:9236600
-
项目类别:
-
资助金额:$75.15万
-
财政年份:2016
-
负责人:JONATHAN KARN
-
依托单位:
Role of non-coding RNA in establishing and maintaining HIV latency
-
批准号:9306785
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2015
-
负责人:JONATHAN KARN
-
依托单位:
Role of non-coding RNA in establishing and maintaining HIV latency
-
批准号:8974679
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2015
-
负责人:JONATHAN KARN
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: